These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 15613049)

  • 1. Improvement of statin-associated myotoxicity by L-carnitine.
    Arduini A; Peschechera A; Giannessi F; Carminati P
    J Thromb Haemost; 2004 Dec; 2(12):2270-1. PubMed ID: 15613049
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cholesterol lowering properties of a complex compound simvastatin with glycyrrhizic acid (simvaglyzin) in experimental models].
    Vavilin VA; Salakhutdinov NF; Ragino IuI; Poliakov NE; Taraban MB; Leshina TV; Stakhneva EM; Liakhovich VV; Nikitin IuP; Tolstikov GA
    Biomed Khim; 2008; 54(3):301-13. PubMed ID: 18712086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of combined ezetimibe/simvastatin treatment and simvastatin monotherapy in patients with non-alcoholic fatty liver disease.
    Abel T; Fehér J; Dinya E; Eldin MG; Kovács A
    Med Sci Monit; 2009 Dec; 15(12):MS6-11. PubMed ID: 19946244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of combining ACE inhibitor and statin in severe experimental nephropathy.
    Zoja C; Corna D; Rottoli D; Cattaneo D; Zanchi C; Tomasoni S; Abbate M; Remuzzi G
    Kidney Int; 2002 May; 61(5):1635-45. PubMed ID: 11967013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for statin-related toxicity: the yield of transaminase and creatine kinase measurements in a primary care setting.
    Smith CC; Bernstein LI; Davis RB; Rind DM; Shmerling RH
    Arch Intern Med; 2003 Mar; 163(6):688-92. PubMed ID: 12639201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simvastatin in severe primary hypercholesterolemia: efficacy, safety, and tolerability in 595 patients over 18 weeks. The Principal Investigators.
    Simons LA
    Clin Cardiol; 1993 Apr; 16(4):317-22. PubMed ID: 8458112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of simvastatin for high-risk hypercholesterolemia.
    Mölgaard J; Wärjerstam-Elf S; Olsson AG
    Am J Cardiol; 1999 Apr; 83(7):1043-8. PubMed ID: 10190517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluvastatin ameliorates endotoxin induced multiple organ failure in conscious rats.
    Chen CH; Lee RP; Wu WT; Liao KW; Hsu N; Hsu BG
    Resuscitation; 2007 Jul; 74(1):166-74. PubMed ID: 17353078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Final conclusions and recommendations of the National Lipid Association Statin Safety Assessment Task Force.
    McKenney JM; Davidson MH; Jacobson TA; Guyton JR;
    Am J Cardiol; 2006 Apr; 97(8A):89C-94C. PubMed ID: 16581336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. l-Carnitine ameliorates the osteoporotic changes and protects against simvastatin induced myotoxicity and hepatotoxicity in glucocorticoid-induced osteoporosis in rats.
    Ahmed SA; Abd El Reheem MH; Elbahy DA
    Biomed Pharmacother; 2022 Aug; 152():113221. PubMed ID: 35671582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term safety of statin-fibrate combination treatment in the management of hypercholesterolaemia in patients with coronary artery disease.
    Feher MD; Foxton J; Banks D; Lant AF; Wray R
    Br Heart J; 1995 Jul; 74(1):14-7. PubMed ID: 7662446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An assessment of statin safety by hepatologists.
    Cohen DE; Anania FA; Chalasani N;
    Am J Cardiol; 2006 Apr; 97(8A):77C-81C. PubMed ID: 16581333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of HMG-CoA reductase inhibitors on skeletal muscles of rabbits.
    Fukami M; Maeda N; Fukushige J; Kogure Y; Shimada Y; Ogawa T; Tsujita Y
    Res Exp Med (Berl); 1993; 193(5):263-73. PubMed ID: 8278673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxicity of a novel HMG-CoA reductase inhibitor in the common marmoset (Callithrix jacchus).
    Owen K; Pick CR; Libretto SE; Adams MJ
    Hum Exp Toxicol; 1994 May; 13(5):357-68. PubMed ID: 8043318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum carnitine. An index of muscle destruction in man.
    DiMauro S; Scott C; Penn AS; Rowland LP
    Arch Neurol; 1973 Mar; 28(3):186-90. PubMed ID: 4685256
    [No Abstract]   [Full Text] [Related]  

  • 16. Simvastatin attenuates cisplatin-induced kidney and liver damage in rats.
    Işeri S; Ercan F; Gedik N; Yüksel M; Alican I
    Toxicology; 2007 Feb; 230(2-3):256-64. PubMed ID: 17196726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of statin dosing intensity on transaminase and creatine kinase.
    Gosmanov AR; Lewis JB
    Am J Med; 2008 Feb; 121(2):e11; author reply e13. PubMed ID: 18261479
    [No Abstract]   [Full Text] [Related]  

  • 18. Adverse events of statin-fenofibric acid versus statin monotherapy: a meta-analysis of randomized controlled trials.
    Geng Q; Ren J; Chen H; Lee C; Liang W
    Curr Med Res Opin; 2013 Mar; 29(3):181-8. PubMed ID: 23323878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Activity of aspartate aminotransferase, alanine aminotransferase, aldolase and creatine kinase in acute intoxication with ethyl alcohol].
    Pitera A; Kolber-Postepska B; Bielak J; Jaklińska A
    Pol Tyg Lek; 1969 Feb; 24(6):203-6. PubMed ID: 5778999
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of simvastatin with Eugenia Jambolana fruit pulp in their effects on alanine transferase, aspartate aminotransferase and creatinine phosphokinase levels of hyperlipidaemic rats.
    Bilal R; Zakaria M; Usman A; Zia A
    J Pak Med Assoc; 2011 Dec; 61(12):1190-4. PubMed ID: 22355964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.